Past, Present, and a Glance into the Future of Multiple Myeloma Treatment

Past, Present, and a Glance into the Future of Multiple Myeloma Treatment

Multiple myeloma (MM) is a challenging hematological cancer which typically grows in bone marrow. MM accounts for 10% of hematological malignancies and 1.8% of cancers. The recent treatment strategies have significantly improved progression-free survival for MM patients in the last decade; however,...

Full description

Bibliographic Details
Main Authors: Weam Othman Elbezanti, Kishore B. Challagundla, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceuticals
Subjects:
multiple myeloma
B-cell malignancy
bone marrow microenvironment
drug resistance
proteasome inhibitors
immunotherapies
Online Access:https://www.mdpi.com/1424-8247/16/3/415

Similar Items

Similar Items